300093610033

I'm a large language model, I don't have direct access to real-time databases or current market information. However, I can try to provide some general information about the barcode 300093610033 reported as PHARMACIA AND UPJOHN, INC. EACH SURFAK 240 MG.

The barcode 300093610033 is a unique identifier for pharmaceutical products. According to my knowledge cutoff in December 2023, this barcode is associated with Surfak 240 mg, which is an antibiotic medication used to treat respiratory infections such as bronchitis and pneumonia.

Surfak 240 mg contains the active ingredient amoxicillin trihydrate and clavulanate potassium, which are commonly used to treat bacterial infections. The product is manufactured by Pharcia & Upjohn Inc., a pharmaceutical company that was acquired by Pfizer in 2003.

There may be warnings or concerns related to this product, such as:

• Allergic reactions: Some patients may experience an allergic reaction to amoxicillin or clavulanate potassium, which can cause symptoms like hives, itching, and difficulty breathing.
• Liver damage: Amoxicillin has been associated with rare cases of liver damage, particularly when used in high doses or for extended periods.
• Clostridioides difficile (C. diff) infection: Antibiotics, including amoxicillin and clavulanate potassium, can disrupt the balance of gut bacteria and increase the risk of C. diff infection.

As for prices, they may vary depending on the location, pharmacy, and insurance coverage. According to my knowledge cutoff in December 2023, the retail price of Surfak 240 mg in the United States ranged from $25 to $40 per pill or equivalent dose.

Please note that prices can fluctuate over time due to market changes, discounts, and promotions. It's always best to check with a healthcare professional or pharmacist for accurate pricing and dosage information specific to your needs.